Latest news

Bioservo outsources all production to partner companies and implements cost savings (regulatory information)

Bioservo signs a distributor agreement with Hidrex for the sales of Carbonhand[®] in Germany

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies


02 Nov, 2022  ·  Regulatory information

Bioservo Technologies AB's rights issue is registered and the trading in Paid Subscription Units ceases

Bioservo Technologies AB (publ) has completed a rights issue of units that closed on October 10, 2022. The rights issue is now registered with the Swedish Companies Registration Office and the last day for trading in paid subscription units (“BTU”) will be Tuesday, November 8, 2022. The record date will be Thursday, November 10, 2022, after which the BTUs are converted into shares and warrants of series 2 on Monday, November 14, 2022.

For further information, please contact
Petter Bäckgren, CEO
+46 8 21 17 10

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North
For more information, please visit